{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:25:45Z","timestamp":1791473145523,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.82001940"],"award-info":[{"award-number":["NO.82001940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hubei Province Key Laboratory Opening Project","award":["NO.2021KFY027"],"award-info":[{"award-number":["NO.2021KFY027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-03001-6","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:27:50Z","timestamp":1734542870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sparstolonin B potentiates the antitumor activity of nanovesicle-loaded drugs by suppressing the phagocytosis of macrophages in vivo"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuefeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhekai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xietong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"3001_CR1","doi-asserted-by":"publisher","first-page":"120467","DOI":"10.1016\/j.biomaterials.2020.120467","volume":"269","author":"P Wu","year":"2021","unstructured":"Wu P, Zhang B, Ocansey DKW, Xu W, Qian H. Extracellular vesicles: a bright star of nanomedicine. Biomaterials. 2021;269:120467. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120467.","journal-title":"Biomaterials"},{"key":"3001_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.semcancer.2019.08.017","volume":"69","author":"VV Tarasov","year":"2021","unstructured":"Tarasov VV, Svistunov AA, Chubarev VN, et al. Extracellular vesicles in cancer nanomedicine. Sem Cancer Biol. 2021;69:212\u201325. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.017.","journal-title":"Sem Cancer Biol"},{"key":"3001_CR3","doi-asserted-by":"publisher","first-page":"1198044","DOI":"10.3389\/fmolb.2023.1198044","volume":"10","author":"S Ghadami","year":"2023","unstructured":"Ghadami S, Dellinger K. The lipid composition of extracellular vesicles: applications in diagnostics and therapeutic delivery. Front Mol Biosci. 2023;10:1198044. https:\/\/doi.org\/10.3389\/fmolb.2023.1198044.","journal-title":"Front Mol Biosci"},{"issue":"10","key":"3001_CR4","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3390\/pharmaceutics14102236","volume":"14","author":"R Du","year":"2022","unstructured":"Du R, Wang C, Zhu L, Yang Y. Extracellular vesicles as Delivery vehicles for therapeutic nucleic acids in Cancer Gene Therapy: Progress and challenges. Pharmaceutics. 2022;14(10):2236. https:\/\/doi.org\/10.3390\/pharmaceutics14102236.","journal-title":"Pharmaceutics"},{"key":"3001_CR5","doi-asserted-by":"crossref","unstructured":"Li J. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. Published online 2023.","DOI":"10.1016\/j.biopha.2023.115087"},{"key":"3001_CR6","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1016\/j.vesic.2022.100004","volume":"1","author":"Y Wen","year":"2022","unstructured":"Wen Y, Fu Q, Soliwoda A, et al. Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles. Extracell Vesicle. 2022;1:100004. https:\/\/doi.org\/10.1016\/j.vesic.2022.100004.","journal-title":"Extracell Vesicle"},{"issue":"5","key":"3001_CR7","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ymthe.2021.01.020","volume":"29","author":"K Dooley","year":"2021","unstructured":"Dooley K, McConnell RE, Xu K, et al. A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties. Mol Ther. 2021;29(5):1729\u201343. https:\/\/doi.org\/10.1016\/j.ymthe.2021.01.020.","journal-title":"Mol Ther"},{"issue":"1","key":"3001_CR8","doi-asserted-by":"publisher","first-page":"1573052","DOI":"10.1080\/20013078.2019.1573052","volume":"8","author":"E Lozano-Andr\u00e9s","year":"2019","unstructured":"Lozano-Andr\u00e9s E, Libregts SF, Toribio V, et al. Tetraspanin\u2010decorated extracellular vesicle\u2010mimetics as a novel adaptable reference material. J Extracell Vesicle. 2019;8(1):1573052. https:\/\/doi.org\/10.1080\/20013078.2019.1573052.","journal-title":"J Extracell Vesicle"},{"issue":"2","key":"3001_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/jps.24251","volume":"104","author":"M Morishita","year":"2015","unstructured":"Morishita M, Takahashi Y, Nishikawa M, et al. Quantitative Analysis of Tissue Distribution of the B16BL6-DerivedexosomesUsing a Streptavidin-Lactadherin Fusion protein and iodine-125-Labeled biotin derivative after intravenous injection in mice. J Pharm Sci. 2015;104(2):705\u201313. https:\/\/doi.org\/10.1002\/jps.24251.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3001_CR10","doi-asserted-by":"publisher","first-page":"26238","DOI":"10.3402\/jev.v4.26238","volume":"4","author":"T Imai","year":"2015","unstructured":"Imai T, Takahashi Y, Nishikawa M, et al. Macrophage-dependent clearance of systemically administered B16BL6\u2010derivedexosomesfrom the blood circulation in mice. J Extracell Vesicle. 2015;4(1):26238. https:\/\/doi.org\/10.3402\/jev.v4.26238.","journal-title":"J Extracell Vesicle"},{"key":"3001_CR11","doi-asserted-by":"publisher","first-page":"114238","DOI":"10.1016\/j.addr.2022.114238","volume":"185","author":"W Ngo","year":"2022","unstructured":"Ngo W, Ahmed S, Blackadar C, et al. Why nanoparticles prefer liver macrophage cell uptake in vivo. Adv Drug Deliv Rev. 2022;185:114238. https:\/\/doi.org\/10.1016\/j.addr.2022.114238.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3001_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12964-023-01236-8","volume":"21","author":"W Lin","year":"2023","unstructured":"Lin W, Fang J, Wei S, et al. Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications. Cell Commun Signal. 2023;21(1):246. https:\/\/doi.org\/10.1186\/s12964-023-01236-8.","journal-title":"Cell Commun Signal"},{"issue":"11","key":"3001_CR13","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.jcyt.2019.10.002","volume":"21","author":"YF Zhang","year":"2019","unstructured":"Zhang YF, Shi JB, Li C. Small extracellular vesicle loading systems in cancer therapy: current status and the way forward. Cytotherapy. 2019;21(11):1122\u201336. https:\/\/doi.org\/10.1016\/j.jcyt.2019.10.002.","journal-title":"Cytotherapy"},{"issue":"18","key":"3001_CR14","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.7150\/thno.27608","volume":"8","author":"Qlong Wang","year":"2018","unstructured":"Wang Qlong, Zhuang X, Sriwastva MK, et al. Blood exosomes regulate the tissue distribution of grapefruit-derived nanovector via CD36 and IGFR1 pathways. Theranostics. 2018;8(18):4912\u201324. https:\/\/doi.org\/10.7150\/thno.27608.","journal-title":"Theranostics"},{"issue":"2","key":"3001_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1182\/blood-2013-03-489732","volume":"123","author":"SC Saunderson","year":"2014","unstructured":"Saunderson SC, Dunn AC, Crocker PR, McLellan AD. CD169 mediates the capture ofexosomesin spleen and lymph node. Blood. 2014;123(2):208\u201316. https:\/\/doi.org\/10.1182\/blood-2013-03-489732.","journal-title":"Blood"},{"issue":"9","key":"3001_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1096\/fj.03-1094fje","volume":"18","author":"A Clayton","year":"2004","unstructured":"Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J. 2004;18(9):977\u20139. https:\/\/doi.org\/10.1096\/fj.03-1094fje.","journal-title":"FASEB J"},{"issue":"9","key":"3001_CR17","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1016\/j.xphs.2021.05.021","volume":"110","author":"A Yamamoto","year":"2021","unstructured":"Yamamoto A, Yasue Y, Takahashi Y, Takakura Y. Determining the role of Surface glycans in the pharmacokinetics of small extracellular vesicles. J Pharm Sci. 2021;110(9):3261\u20137. https:\/\/doi.org\/10.1016\/j.xphs.2021.05.021.","journal-title":"J Pharm Sci"},{"issue":"11","key":"3001_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tcb.2015.08.003","volume":"25","author":"K Segawa","year":"2015","unstructured":"Segawa K, Nagata S. An apoptotic \u2018Eat me\u2019 Signal: phosphatidylserine exposure. Trends Cell Biol. 2015;25(11):639\u201350. https:\/\/doi.org\/10.1016\/j.tcb.2015.08.003.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"3001_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.xphs.2016.07.022","volume":"106","author":"A Matsumoto","year":"2017","unstructured":"Matsumoto A, Takahashi Y, Nishikawa M, et al. Role of phosphatidylserine-derived negative surface charges in the Recognition and Uptake of Intravenously injected B16BL6-Derived exosomes by macrophages. J Pharm Sci. 2017;106(1):168\u201375. https:\/\/doi.org\/10.1016\/j.xphs.2016.07.022.","journal-title":"J Pharm Sci"},{"issue":"5","key":"3001_CR20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47-SIRP\u03b1 Immune Checkpoint. Immunity. 2020;52(5):742\u201352. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.011.","journal-title":"Immunity"},{"issue":"1","key":"3001_CR21","doi-asserted-by":"publisher","first-page":"1806444","DOI":"10.1080\/20013078.2020.1806444","volume":"9","author":"Z Belhadj","year":"2020","unstructured":"Belhadj Z, He B, Deng H, et al. A combined eat me\/don\u2019t eat me strategy based on extracellular vesicles for anticancer nanomedicine. J Extracell Vesicle. 2020;9(1):1806444. https:\/\/doi.org\/10.1080\/20013078.2020.1806444.","journal-title":"J Extracell Vesicle"},{"issue":"7659","key":"3001_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498\u2013503. https:\/\/doi.org\/10.1038\/nature22341.","journal-title":"Nature"},{"key":"3001_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2021.01.001","volume":"31","author":"N Parada","year":"2021","unstructured":"Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res. 2021;31:61\u201374. https:\/\/doi.org\/10.1016\/j.jare.2021.01.001.","journal-title":"J Adv Res"},{"issue":"1","key":"3001_CR24","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1038\/s41598-017-05541-4","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L, Zhang B, Zheng W, Kang M, Chen Q, Qin W, Li C, Zhang Y, Shao Y, Wu Y. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K\/Akt\/FoxO1 pathway. Sci Rep. 2017;7(1):5384. https:\/\/doi.org\/10.1038\/s41598-017-05541-4. PMID: 28710412; PMCID: PMC5511275.","journal-title":"Sci Rep"},{"issue":"2","key":"3001_CR25","doi-asserted-by":"publisher","first-page":"100511","DOI":"10.1016\/j.xpro.2021.100511","volume":"2","author":"S Daemen","year":"2021","unstructured":"Daemen S, Chan MM, Schilling JD. Comprehensive analysis of liver macrophage composition by flow cytometry and immunofluorescence in murine NASH. STAR Protocols. 2021;2(2):100511. https:\/\/doi.org\/10.1016\/j.xpro.2021.100511.","journal-title":"STAR Protocols"},{"issue":"1","key":"3001_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12951-024-02705-z","volume":"22","author":"C Ye","year":"2024","unstructured":"Ye C, Yan C, Bian SJ, et al. Momordica charantia L.-derived exosome-like nanovesicles stabilize p62 expression to ameliorate doxorubicin cardiotoxicity. J Nanobiotechnol. 2024;22(1):464. https:\/\/doi.org\/10.1186\/s12951-024-02705-z.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"3001_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/pharmaceutics16060739","volume":"16","author":"LM Paschoal Barbosa","year":"2024","unstructured":"Paschoal Barbosa LM, Gomes ER, Barros ALB, et al. Hybrid Nanosystem formed by DOX-Loaded liposomes and Extracellular vesicles from MDA-MB-231 is effective against breast Cancer cells with different molecular profiles. Pharmaceutics. 2024;16(6):739. https:\/\/doi.org\/10.3390\/pharmaceutics16060739.","journal-title":"Pharmaceutics"},{"issue":"37","key":"3001_CR28","doi-asserted-by":"publisher","first-page":"2300527","DOI":"10.1002\/smll.202300527","volume":"19","author":"GB Kim","year":"2023","unstructured":"Kim GB, Kim S, Hwang YH, et al. Harnessing Oncolytic Extracellular vesicles for Tumor cell-preferential cytoplasmic delivery of misfolded proteins for Cancer Immunotherapy. Small. 2023;19(37):2300527. https:\/\/doi.org\/10.1002\/smll.202300527.","journal-title":"Small"},{"issue":"1","key":"3001_CR29","doi-asserted-by":"publisher","first-page":"2205247","DOI":"10.1002\/advs.202205247","volume":"10","author":"M Sun","year":"2023","unstructured":"Sun M, Shi W, Wu Y, et al. Immunogenic nanovesicle-Tandem\u2010augmented chemoimmunotherapy via efficient Cancer\u2010homing delivery and optimized ordinal\u2010interval Regime. Adv Sci. 2023;10(1):2205247. https:\/\/doi.org\/10.1002\/advs.202205247.","journal-title":"Adv Sci"},{"issue":"8","key":"3001_CR30","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1021\/acs.molpharmaceut.3c00363","volume":"20","author":"SK Kumar","year":"2023","unstructured":"Kumar SK, Sasidhar MV. Recent trends in the Use of Small Extracellular vesicles as Optimal Drug Delivery vehicles in Oncology. Mol Pharm. 2023;20(8):3829\u201342. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00363.","journal-title":"Mol Pharm"},{"key":"3001_CR31","doi-asserted-by":"publisher","unstructured":"Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer cells in the liver. In: Prakash YS, editor. Comprehensive Physiology. 1st ed. Wiley; 2013. pp. 785\u201397. https:\/\/doi.org\/10.1002\/cphy.c120026.","DOI":"10.1002\/cphy.c120026"},{"issue":"9","key":"3001_CR32","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","volume":"55","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, Scott CL. Liver macrophages in health and disease. Immunity. 2022;55(9):1515\u201329. https:\/\/doi.org\/10.1016\/j.immuni.2022.08.002.","journal-title":"Immunity"},{"issue":"5","key":"3001_CR33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jhep.2010.04.037","volume":"53","author":"M Kinoshita","year":"2010","unstructured":"Kinoshita M, Uchida T, Sato A, et al. Characterization of two F4\/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol. 2010;53(5):903\u201310. https:\/\/doi.org\/10.1016\/j.jhep.2010.04.037.","journal-title":"J Hepatol"},{"issue":"8","key":"3001_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.molmed.2020.05.006","volume":"26","author":"ME Simpson","year":"2020","unstructured":"Simpson ME, Petri WA. TLR2 as a therapeutic target in bacterial infection. Trends Mol Med. 2020;26(8):715\u20137. https:\/\/doi.org\/10.1016\/j.molmed.2020.05.006.","journal-title":"Trends Mol Med"},{"key":"3001_CR35","unstructured":"Kawai T. Toll-like receptor signaling pathways. Frontiers in Immunology."},{"issue":"1","key":"3001_CR36","doi-asserted-by":"publisher","first-page":"113214","DOI":"10.1016\/j.yexcr.2022.113214","volume":"417","author":"Y Lyu","year":"2022","unstructured":"Lyu Y, Duan B, Liu Z, et al. Sparstolonin B inhibits pancreatic adenocarcinoma through the NF-\u03baB signaling pathway. Exp Cell Res. 2022;417(1):113214. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113214.","journal-title":"Exp Cell Res"},{"key":"3001_CR37","doi-asserted-by":"crossref","unstructured":"Wang Y. Application of exosome engineering modification in targeted delivery of therapeutic drugs. Biochem Pharmacol. Published online 2023.","DOI":"10.1016\/j.bcp.2023.115691"},{"issue":"7","key":"3001_CR38","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00216-022-04248-4","volume":"415","author":"C Chen","year":"2023","unstructured":"Chen C, Li Y, Wang Q, Cai N, Wu L, Yan X. Single-particle assessment of six different drug-loading strategies for incorporating doxorubicin into small extracellular vesicles. Anal Bioanal Chem. 2023;415(7):1287\u201398. https:\/\/doi.org\/10.1007\/s00216-022-04248-4.","journal-title":"Anal Bioanal Chem"},{"issue":"13","key":"3001_CR39","doi-asserted-by":"publisher","first-page":"e12163","DOI":"10.1002\/jev2.12163","volume":"10","author":"C Chen","year":"2021","unstructured":"Chen C, Sun M, Wang J, Su L, Lin J, Yan X. Active cargo loading into extracellular vesicles: highlights the heterogeneous encapsulation behaviour. J Extracell Vesicle. 2021;10(13):e12163. https:\/\/doi.org\/10.1002\/jev2.12163.","journal-title":"J Extracell Vesicle"},{"issue":"20","key":"3001_CR40","doi-asserted-by":"publisher","first-page":"2105274","DOI":"10.1002\/advs.202105274","volume":"9","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Zhao W, Wu C, et al. Lemon-Derived Extracellular vesicles Nanodrugs enable to efficiently overcome Cancer Multidrug Resistance by Endocytosis\u2010Triggered Energy Dissipation and Energy Production reduction. Adv Sci. 2022;9(20):2105274. https:\/\/doi.org\/10.1002\/advs.202105274.","journal-title":"Adv Sci"},{"key":"3001_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jconrel.2021.05.001","volume":"334","author":"SE Emam","year":"2021","unstructured":"Emam SE, Elsadek NE, Abu Lila AS, et al. Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylatedexosomesin mice. J Controlled Release. 2021;334:327\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2021.05.001.","journal-title":"J Controlled Release"},{"key":"3001_CR42","doi-asserted-by":"publisher","first-page":"1211833","DOI":"10.3389\/fcell.2023.1211833","volume":"11","author":"M Cie\u015blik","year":"2023","unstructured":"Cie\u015blik M, Bryniarski K, Nazimek K. Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared? Front Cell Dev Biol. 2023;11:1211833. https:\/\/doi.org\/10.3389\/fcell.2023.1211833.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3001_CR43","doi-asserted-by":"publisher","first-page":"e2101387","DOI":"10.1002\/adhm.202101387","volume":"11","author":"RJ Bose","year":"2022","unstructured":"Bose RJ, Kumar US, Garcia-Marques F, et al. Engineered Cell-Derived vesicles displaying targeting peptide and functionalized with nanocarriers for therapeutic microRNA delivery to Triple-negative breast Cancer in mice. Adv Healthc Mater. 2022;11(5):e2101387. https:\/\/doi.org\/10.1002\/adhm.202101387.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"3001_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, Rao L, Duo Y. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8(1):207. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"30","key":"3001_CR45","doi-asserted-by":"publisher","first-page":"26470","DOI":"10.1074\/jbc.M111.227934","volume":"286","author":"Q Liang","year":"2011","unstructured":"Liang Q, Wu Q, Jiang J, et al. Characterization of sparstolonin B, a Chinese Herb-derived compound, as a selective toll-like receptor antagonist with potent anti-inflammatory properties. J Biol Chem. 2011;286(30):26470\u20139. https:\/\/doi.org\/10.1074\/jbc.M111.227934.","journal-title":"J Biol Chem"},{"issue":"2","key":"3001_CR46","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cyto.2014.12.003","volume":"75","author":"Q Liang","year":"2015","unstructured":"Liang Q, Dong S, Lei L, et al. Protective effects of sparstolonin B, a selective TLR2 and TLR4 antagonist, on mouse endotoxin shock. Cytokine. 2015;75(2):302\u20139. https:\/\/doi.org\/10.1016\/j.cyto.2014.12.003.","journal-title":"Cytokine"},{"issue":"8","key":"3001_CR47","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/brainsci10080532","volume":"10","author":"D Bose","year":"2020","unstructured":"Bose D, Mondal A, Saha P, et al. TLR antagonism by sparstolonin B alters Microbial signature and modulates gastrointestinal and neuronal inflammation in Gulf War Illness Preclinical Model. Brain Sci. 2020;10(8):532. https:\/\/doi.org\/10.3390\/brainsci10080532.","journal-title":"Brain Sci"},{"issue":"2","key":"3001_CR48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/1541-7786.MCR-20-0650","volume":"19","author":"E Alsina-Sanchis","year":"2021","unstructured":"Alsina-Sanchis E, M\u00fclfarth R, Moll I, Mogler C, Rodriguez-Vita J, Fischer A. Intraperitoneal Oil Application Causes Local Inflammation with depletion of Resident Peritoneal macrophages. Mol Cancer Res. 2021;19(2):288\u2013300. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0650.","journal-title":"Mol Cancer Res"},{"issue":"10","key":"3001_CR49","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/bmc.3447","volume":"29","author":"N Zou","year":"2015","unstructured":"Zou N, Liang Q, Li P, et al. Determination of sparstolonin B by ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry: application to pharmacokinetic study of sparstolonin B in rat plasma. Biomed Chromatogr. 2015;29(10):1486\u201391. https:\/\/doi.org\/10.1002\/bmc.3447.","journal-title":"Biomed Chromatogr"},{"key":"3001_CR50","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.biopha.2017.12.047","volume":"98","author":"YM Tang","year":"2018","unstructured":"Tang YM, Cao QY, Guo XY, et al. Inhibition of p38 and ERK1\/2 pathways by sparstolonin B suppresses inflammation-induced melanoma metastasis. Biomed Pharmacother. 2018;98:382\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2017.12.047.","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03001-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-03001-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03001-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T18:03:16Z","timestamp":1734544996000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-03001-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3001"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-03001-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental designs and protocols involving animals were approved by the Laboratory Animal Welfare and Ethics Committee of Renmin Hospital of Wuhan University. All procedures were conducted in accordance with the Declaration of Helsinki and standard guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"759"}}